We are pioneering non-invasive, early screening of cancer risk in dogs.

Our scientifically proven, patent-pending in-vitro screening test is non-invasive, highly accurate, and convenient, requiring only a urine sample. Through early cancer detection, we can help save their lives.

Cancer is the leading cause of death in dogs.

There are over 90 million dogs in the US, and cancer is the leading cause of death in them. Unfortunately, 1 in 4 dogs, and almost half of dogs over the age of 10, will develop cancer at some stage in their life. Dogs often die from cancer because it is too advanced to be treated when detected. Few symptoms are evident in early-stage cancer, yet cancer is far more difficult to treat as it progresses to an advanced stage when symptoms become apparent. Therefore, early detection of cancer is crucial in treating and saving them.
Source: American Veterinary Medical Association (AVMA)

1 in 4 dogs will
develop cancer.

Almost half of dogs over
the age of 10will develop cancer.

Cancer is the leading cause of death in dogs.




Bloat or Gastric Dilatation Volvulus


Old Age & Other


Kidney Failure


Immune-Mediated Disease


Addison's Disease


Heart Disease and Stroke



There is an urgent need to develop a novel economical and non-invasive method to routinely screen for cancer before it advances in dogs.

  • Too Expensive

  • Invasive

  • Too Late

What if a single urine sample from your dog can tell you his/her cancer risk?

Introducing A.C.D.™ Test (Animal Cancer Dx Test)

A patent-pending cancer screening test that combines its proprietary technology with the highly sensitive olfactory sensory functions of C. elegans to accurately measure their ability to preferentially discriminate and move toward cancer-positive dog urine samples. This novel test is non-invasive, painless, and can detect cancer risk at an early stage. If dogs take the test regularly, you as an owner will suffer less both mentally and emotionally and incur fewer financial burdens in case cancer is diagnosed.

Why C. elegans? Superior olfactory sensors

C. elegans is the first multicellular organism to have its entire genome sequenced, making it a useful model organism in biological research. Because it has no eyes or ears, it relies on smell to navigate its environment and detect food. C. elegans has an excellent sense of smell and possesses approximately 1.5 times as many different types of olfactory receptors as a dog.

  • Convenient

    A single urine sample is all you need.

  • Economical

    Traditional methods can cost $700 or more.

  • Non Invasive

    No needle necessary. Painless.

  • Multi-Cancer Detection

    Lymphoma, HSA, MCT, and Melanoma. Other cancers are being further tested .

  • Early Screening

    Testing possible before any clinical signs.

  • High Accuracy

    89.8% Accuracy among the 4 most common cancers.

Recommended by Veterinary Oncologists

"Prevention is difficult because we don’t know the causes of most cancers. I think, rather than trying to prevent cancer, identifying it early and treating it quickly is the better strategy. The A.C.D. Test is a perfect screening test for early cancer detection." - Dr. Dave Ruslander, a veterinary oncologist and past president of the Veterinary Cancer Society."

Trusted by Dog Owners

"My dog's urinalysis and blood work came fine, but I knew something was not right about her, so I had her take the A.C.D. Test. It turned out she had cancer, and my vet was able to find cancer in her. We put a treatment plan for her, and she's doing great!" - Ashley K. from Raleigh, NC

Important Disclosure on Animal Cancer Dx Test Results

The early screening test results of Animal Cancer Dx should not be interpreted as a firm diagnosis. Animal Cancer Dx is an assessment test based on clinical studies, which aim to assess cancer risk at the time the test was performed. The test result of “cancer risk was not detected” does not confirm the absence of cancer, and the test result of “high cancer risk” does not prove the presence of cancer. Pet owners are advised not to interpret the result of Animal Cancer Dx on their own, but to discuss with their veterinarians, according to the health conditions of their companion animals, how to interpret the result and whether or not further tests, such as ultrasound, biopsy, MRI, or CT scan are required.

Join the Pioneering Way in Early Cancer Detection for Dogs

If you are eager to incorporate breakthrough innovation into your veterinary practice, we would love to partner with you. Be among the first to offer our pioneering multi-cancer early detection test to your canine patients. Provide your name and email address and we will reach out as we expand our rollout.